Fatal alveolar hemorrhage and Abciximab (ReoProTM) therapy for acute myocardial infarction
โ Scribed by Khanlou, Homayoun ;Tsiodras, Sotirios ;Eiger, Glenn ;Abousy, Khalid ;Goldberg, Steven ;Nakhjavan, Fred ;Yazdanfar, Shahriar
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 68 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0098-6569
No coin nor oath required. For personal study only.
โฆ Synopsis
We describe two cases of diffuse alveolar hemorrhage and development of ARDS in patients who underwent percutaneous transluminal coronary angioplasty (PTCA) with stenting in whom Abciximab (ReoPro TM ) was used in combination with other agents interfering with the hemostatic mechanism. The development of pulmonary infiltrates, associated with a fall in hemoglobin after the administration of Abciximab, should strongly suggest the possibility of diffuse alveolar hemorrhage. Physicians should be aware of the possible association between the use of Abciximab and the development of alveolar hemorrhage.
๐ SIMILAR VOLUMES
Stent implantation in the setting of failed rescue angiopiasty after failed thromboiytic therapy for acute myocardial infarction Is considered a high-risk procedure, because of the possibliity of stent thrombosis. Withholding anticoagulation in such a patient who also has a bleeding dlathesis may fu
Recent evidence suggests that coronary stenting and the use of antiplatelet agents during coronary interventions will improve the outcome of patients with acute myocardial infarction (AMI). We describe the management of AMI in a 30-year-old woman, 38 weeks pregnant, with primary stenting and antipla